Structure-and ligand-based drug design: Concepts, approaches, and challenges
It takes more than 10 years to bring a drug to the market and costs an average cost of US
$2.6 billion. Computer-aided drug design (CADD) saves up to 30% of the time and money of …
$2.6 billion. Computer-aided drug design (CADD) saves up to 30% of the time and money of …
Clinical approach to diabetic cardiomyopathy: a review of human studies
R Tarquini, L Pala, S Brancati, G Vannini… - Current Medicinal …, 2018 - ingentaconnect.com
Background: Diabetic Cardiomyopathy (DC) has been defined as a distinct entity
characterized by the presence of diastolic or systolic cardiac dysfunction in a diabetic patient …
characterized by the presence of diastolic or systolic cardiac dysfunction in a diabetic patient …
Employing comparative QSAR techniques for the recognition of dibenzofuran and dibenzothiophene derivatives toward MMP-12 inhibition
Among various matrix metalloproteinases (MMPs), MMP-12 is one of the potential targets for
cancer and other diseases. However, none of the MMP-12 inhibitors has passed the clinical …
cancer and other diseases. However, none of the MMP-12 inhibitors has passed the clinical …
Novel Macrocyclic Bidentate Schiff's base Hg (II) Complexes, Hirshfeld surface analysis, NCI analysis, and Antimicrobial activity studies
AK Pal, A Jaiswal, R Ravi, KK Yadav, DK Sahu… - Polyhedron, 2024 - Elsevier
The authors synthesized and characterized macrocyclic complex compounds of the general
formula [M-LX2], where M is Hg (II). They created a number of unimolecular Schiff base …
formula [M-LX2], where M is Hg (II). They created a number of unimolecular Schiff base …
Synthesis, biological evaluation and docking study of a new series of di-substituted benzoxazole derivatives as selective COX-2 inhibitors and anti-inflammatory …
A new series of substituted-N-(3, 4-dimethoxyphenyl)-benzoxazole derivatives 13a–13p was
synthesized and evaluated in vitro for their COX (I and II) inhibitory activity, in vivo anti …
synthesized and evaluated in vitro for their COX (I and II) inhibitory activity, in vivo anti …
Synthesis, DFT study, molecular docking and insecticidal evaluation of some pyrazole-based tetrahydropyrimidine derivatives
Abstract The building block synthon, 1-(4-(1, 3-diphenyl-1 H-pyrazol-4-yl)-6-methyl-2-thioxo-
1, 2, 3, 4-tetrahydropyrimidin-5-yl) ethan-1-one was efficiently synthesized by Biginelli …
1, 2, 3, 4-tetrahydropyrimidin-5-yl) ethan-1-one was efficiently synthesized by Biginelli …
5, 6-Dihydropyrimidine-1 (2H)-carbothioamides: Synthesis, in vitro GABA-AT screening, anticonvulsant activity and molecular modelling study
Even after considerable advances in the field of epilepsy treatment, convulsions are
inefficiently controlled by standard drug therapy. Herein, a series of pyrimidine …
inefficiently controlled by standard drug therapy. Herein, a series of pyrimidine …
Designing novel inhibitors against falcipain-2 of Plasmodium falciparum
Coumarin containing pyrazoline derivatives have been synthesized and tested as inhibitors
of in vitro development of a chloroquine-sensitive (MRC-02) and chloroquine-resistant (RKL …
of in vitro development of a chloroquine-sensitive (MRC-02) and chloroquine-resistant (RKL …
Design, synthesis and evaluation of newer 5, 6-dihydropyrimidine-2 (1H)-thiones as GABA-AT inhibitors for anticonvulsant potential
Abstract Several new 5, 6-dihydropyrimidine-2 (1H)-thione derivatives have been prepared
and investigated for their potencies for anticonvulsant activity against maximal electroshock …
and investigated for their potencies for anticonvulsant activity against maximal electroshock …
Design, synthesis, and docking study of pyrimidine–triazine hybrids for GABA estimation in animal epilepsy models
A series of new pyrimidine–triazine hybrids (4a–t) was designed and synthesized, from
which potent anticonvulsant agents were identified. Most of the compounds exhibited …
which potent anticonvulsant agents were identified. Most of the compounds exhibited …